Fenerich, Bruna Alves <br/><br/>
NT157 has antineoplastic effects and inhibits IRS1/2 and STAT3/5 in JAK2  [electronic resource] 

 -  Signal transduction and targeted therapy  01 2020 
 - 5 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>2059-3635 
<br/><br/><label>Standard No.: </label>10.1038/s41392-019-0102-5  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Apoptosis--drug effects<br/>Cell Cycle Checkpoints--drug effects<br/>Cell Line, Tumor<br/>Cell Proliferation--drug effects<br/>Cell Survival--drug effects<br/>Gene Expression Regulation, Neoplastic--drug effects<br/>Humans<br/>Insulin Receptor Substrate Proteins--antagonists & inhibitors<br/>Janus Kinase 2--genetics<br/>Myeloproliferative Disorders--drug therapy<br/>Polycythemia Vera--drug therapy<br/>Pyrogallol--analogs & derivatives<br/>STAT3 Transcription Factor--antagonists & inhibitors<br/>STAT5 Transcription Factor--antagonists & inhibitors<br/>Sulfonamides--pharmacology